NOVA BIO-PHARMA TECHNOLOGIES LIMITED
NOVA BIO-PHARMA TECHNOLOGIES LIMITED is a private limited company registered in the United Kingdom, under 06936355, incorporated on 17 June 2009. The company is currently active. Operates in the manufacture of basic pharmaceutical products sector (SIC 21100). The company has been operating for 16 years. Registered office address: LE18 4YL Wigston, the United Kingdom. Directors include MRS KAREN ALISON LEISHMAN, MR SAMOOH DISHAL DE COSTA, and MR JAMES ANDREW PITT WHITE, and 1 other. Sole shareholder is NOVA BIO-PHARMA HOLDINGS LIMITED. Associated with 11 related entities, including NOVA ADVANCED TISSUE ENGINEERING LIMITED, 06951295, and NOVA BIO-PHARMA HOLDINGS LIMITED. No sanctions, PEP status, or adverse risk signals are currently on record. Data sourced from UK Companies House.
Official Identifiers
Registered Address
MARTIN HOUSE
GLOUCESTER CRESCENT
LEICESTERSHIRE
LE18 4YL WIGSTON
the United Kingdom
Signal Intelligence
No sanctions, PEP status, or adverse risk signals are currently on record for this entity.
Key Management & Controllers
Associated Entities
Companies sharing one or more directors or officers with this entity.
Change Log (3)
| Date | Change | Details |
|---|---|---|
| 2026-05-08 | DIRECTOR ADDED | Samooh Dishal De Costa (director) |
| 2026-05-08 | DIRECTOR ADDED | Dr Peter John Pitt White (director) |
| 2026-05-08 | DIRECTOR ADDED | James Andrew Pitt White (director) |
Source Records (1)
| companieshouse | 06936355 | 2026-06-01 | open_in_new |